Curevo, a Seattle-based biotech startup developing a vaccine against shingles, raised $110 million in a Series B round.
The pharma will acquire Araris Biotech to gain access to three preclinical ADCs and a linking technology Araris claims is ...
Chinese drug maker Akeso, whose new cancer drug has outperformed a leading Western peer in clinical studies, is being hailed ...
Sutro Biopharma, a Bay Area oncology biotech company, is laying off around half its staff, switching up its leadership team ...
There are few signs the industry responsible for more than 115,000 Massachusetts jobs is pulling out of its four-year downswing.
Partex's platform will provide comprehensive analyses, including target identification, indication expansion, and molecular profiling, ultimately accelerating the process of bringing innovative ...
In this article, we will be taking a look at the 15 best biotech stocks to buy according to billionaires. Although biotech ...
Offering free solutions can generate goodwill and strengthen relationships with both existing and potential customers. When a ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...
Zacks Investment Research on MSN5h
Here's Why Krystal Biotech, Inc. (KRYS) is a Strong Momentum StockIt doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback